The expression of insulin signaling and N-methyl-D-aspartate receptor genes in areas of gray matter atrophy is associated with cognitive function in type 2 diabetes

BackgroundType 2 diabetes (T2DM) is associated with brain abnormalities and cognitive dysfunction, including increased risk for Alzheimer's disease. However, the mechanisms of T2DM-related dementia remain poorly understood.ObjectiveWe evaluated the molecular properties of gray matter atrophy an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Alzheimer's disease Vol. 107; no. 3; p. 1054
Main Authors: Kesler, Shelli R, Cuevas, Heather, Lewis, Kimberly A, Franco-Rocha, Oscar Y, Flowers, Elena
Format: Journal Article
Language:English
Published: United States 01.10.2025
Subjects:
Aged
Aged, 80 and over
Atrophy - pathology
Brain - metabolism
Brain - pathology
Cognition - physiology
Cognitive Dysfunction - genetics
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - diagnostic imaging
Diabetes Mellitus, Type 2 - genetics
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - pathology
Diabetes Mellitus, Type 2 - psychology
Female
Gray Matter - diagnostic imaging
Gray Matter - metabolism
Gray Matter - pathology
Humans
Insulin - metabolism
Magnetic Resonance Imaging
Male
Middle Aged
Receptors, N-Methyl-D-Aspartate - genetics
Receptors, N-Methyl-D-Aspartate - metabolism
Retrospective Studies
Signal Transduction - genetics
Signal Transduction - physiology
type 2 diabetes
Alzheimer's disease
transcriptome
neuroimaging
ISSN:1875-8908, 1875-8908
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundType 2 diabetes (T2DM) is associated with brain abnormalities and cognitive dysfunction, including increased risk for Alzheimer's disease. However, the mechanisms of T2DM-related dementia remain poorly understood.ObjectiveWe evaluated the molecular properties of gray matter atrophy and cognitive decline in T2DM.MethodsWe obtained retrospective data from the Mayo Clinic Study of Aging for 271 individuals with T2DM and 542 non-diabetic controls (age 51-89, 62% male). We identified regions of significant gray matter atrophy in the T2DM group and then determined which genes were significantly expressed in these brain regions using imaging transcriptomics. We selected 15 candidate genes involved in insulin signaling, lipid metabolism, amyloid processing, N-methyl-D-aspartate-mediated neurotransmission, and calcium signaling.ResultsThe T2DM group demonstrated gray matter atrophy in regions of the default mode, frontal-parietal, and sensorimotor networks (p < 0.05 cluster threshold corrected for false discovery rate, FDR). , and genes were significantly expressed in these same regions (R  > 0.10, p < 0.03, FDR corrected). Bayesian network analysis indicated significant directional paths among all 5 genes as well as the Clinical Dementia Rating score. Directional paths among genes were significantly altered in the T2DM group (Structural Hamming Distance = 12, p = 0.004), with expression becoming more important in the context of T2DM-related pathophysiology.ConclusionsAlterations of brain transcriptome patterns occurred in the absence of significant cognitive deficit or cortical amyloid accumulation and in the context of lower incidence of genotype, potentially representing an early biomarker of T2DM-related dementia.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1875-8908
1875-8908
DOI:10.1177/13872877251364906